title: Losartan in post-transplant erythrocytosis.
authors.forename: P J
authors.initials: PJ
authors.lastname: Conlon
authors.forename: S R
authors.initials: SR
authors.lastname: Smith
authors.forename: D W
authors.initials: DW
authors.lastname: Butterly
authors.forename: D C
authors.initials: DC
authors.lastname: Brennan
mesh_terms: D000328:Adult; D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D001713:Biphenyl Compounds / Q000627:therapeutic use*; D006801:Humans; D007093:Imidazoles / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000009:adverse effects*; D019808:Losartan; D011086:Polycythemia / Q000209:etiology* / Q000517:prevention & control; D013777:Tetrazoles / Q000627:therapeutic use*
chemical_list: D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D001713:Biphenyl Compounds; D007093:Imidazoles; D013777:Tetrazoles; D019808:Losartan